---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-002258"
form_type: "8-K"
ticker: "RYTM"
cik: "0001649904"
company_name: "RHYTHM PHARMACEUTICALS, INC."
filed_at: "2023-01-09T23:59:59+00:00"
generated_at: "2026-06-20T17:54:56.427109+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "low"
source: SEC EDGAR
---

# Rhythm Pharmaceuticals furnishes corporate slide deck; no material changes disclosed

## Summary
- Slide deck posted to investors section of company website on January 9, 2023.
- Deck covers setmelanotide for rare MC4R pathway diseases; no new data or milestones.
- Exhibit contains only title slide and forward-looking statements; no financial or pipeline updates.

## SEC filing metadata
- accession: 0001104659-23-002258
- form_type: 8-K
- ticker: RYTM
- cik: 0001649904
- company_name: RHYTHM PHARMACEUTICALS, INC.
- filed_at: 2023-01-09T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1649904/000110465923002258/0001104659-23-002258-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1649904/000110465923002258/tm232248d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-002258
- JSON: https://secwatch.observer/filing/0001104659-23-002258.json
- Plain text: https://secwatch.observer/filing/0001104659-23-002258.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.